Irreversible enzyme inhibitors. CXLI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 1-[p-(p-fluorosulfonylphenylureidomethyl)phenyl]-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine.
D000818:Animals; D001555:Benzene Derivatives; D001665:Binding Sites; D002219:Carbamates; D055598:Chemical Phenomena; D002621:Chemistry; D005459:Fluorides; D005493:Folic Acid Antagonists; D007422:Intestines / Q000201:enzymology; D007939:Leukemia L1210 / Q000201:enzymology*; D008099:Liver / Q000201:enzymology*; D051379:Mice; D013154:Spleen / Q000201:enzymology; D013451:Sulfonic Acids / Q000138:chemical synthesis; D014227:Triazines / Q000138:chemical synthesis
D001555:Benzene Derivatives; D002219:Carbamates; D005493:Folic Acid Antagonists; D013451:Sulfonic Acids; D014227:Triazines; D005459:Fluorides